Cardio Diagnostics Holdings, Inc.

Name: Cardio Diagnostics Holdings, Inc. standardized financial statements, quarterly
Creator: Listed

CDIONasdaqCIK 1870144HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$5.4k, Q2 FY2026

Operating income−$1.5m, Q2 FY2026

Net income−$1.5m, Q2 FY2026

Cardio Diagnostics Holdings, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$k	10.0	5.3	15.9	7.9	6.6	4.5	0.9	7.5	2.9	3.6	2.7	5.4
Research and development	$k	38.7	7.5	10.8	7.3	5.2	205	119	179	189	287	130	163
Selling, general and administrative	$k	not reported	not reported	not reported	1,290	1,416	not reported	not reported	1,686	1,714	not reported	not reported	not reported
Operating income	$k	(1,444)	(1,542)	(4,158)	(1,282)	(1,409)	(1,516)	(1,631)	(1,679)	(1,712)	(1,463)	(1,785)	(1,498)
Interest expense	$k	570	96.1	5.8	5.8	3.9	3.1	4.7	4.7	3.1	2.3	3.4	3.4
Income tax	$k	0.0	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Net income	$k	(1,932)	(1,389)	(4,164)	(1,288)	(1,413)	(1,519)	(1,635)	(1,683)	(1,715)	(1,465)	(1,788)	(1,501)
Diluted EPS	$ per share	(0.16)	not reported	(5.93)	(1.71)	(1.73)	not reported	(0.97)	(0.97)	(0.98)	not reported	(0.63)	(0.51)
Basic EPS	$ per share	(0.16)	not reported	(5.93)	(1.71)	(1.73)	not reported	(0.97)	(0.97)	(0.98)	not reported	(0.63)	(0.51)

Balance sheet

Cash and equivalents$0, Q2 FY2026

Shareholders' equity$7.4m, Q2 FY2026

Cardio Diagnostics Holdings, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Current assets	$m	4.5	2.8	2.6	2.1	2.6	8.8	10.5	8.7	6.9	5.9	7.7	6.2
Total assets	$m	6.0	4.5	4.3	4.0	4.5	10.6	12.3	10.4	8.8	7.8	9.6	7.9
Current liabilities	$m	3.0	0.8	0.7	0.4	0.3	0.6	0.5	0.4	0.4	0.6	0.5	0.4
Total liabilities	$m	3.7	1.5	1.3	0.9	0.8	1.1	0.9	0.7	0.6	0.8	0.7	0.5
Shareholders' equity	$m	2.3	3.0	3.0	3.1	3.7	9.6	11.4	9.7	8.2	7.0	8.9	7.4

Cash flow

Operating cash flow−$1.3m, Q2 FY2026

Capital expenditure$0, Q2 FY2026

Cardio Diagnostics Holdings, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(1,045)	(1,686)	(1,233)	(1,210)	(1,157)	(1,392)	(1,400)	(1,571)	(1,393)	(1,362)	(1,562)	(1,342)
Capital expenditure	$k	12.6	537	20.0	168	23.2	3.6	5.8	18.7	163	0.0	1.8	0.0

Diluted shares (weighted)2.96m, Q2 FY2026

Cardio Diagnostics Holdings, Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	6.6	9.5	10.2	11.9	0.7	0.8	0.8	1.7	1.7	1.8	2.8	3.0

Shares outstanding: 2.96m at Aug 7, 2026, from the cover of the 10-Q filed Aug 7, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.